Company Filing History:
Years Active: 2025
Title: Innovations of Chengxia Shu in Medicinal Chemistry
Introduction
Chengxia Shu is a notable inventor in the field of medicinal chemistry, based in Jiangsu, China. He has made significant contributions to the development of pharmaceutical compounds, particularly in addressing challenges related to drug resistance.
Latest Patents
Chengxia Shu holds a patent for an innovative compound titled "SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same." This invention focuses on the synthesis, preparation method, and application of an inhibitor that targets both SHP2 and CDK4/6. The compound comprises three specific formulas and their pharmaceutically acceptable variants. The invention aims to overcome issues of drug resistance and poor efficacy associated with existing inhibitors, marking a significant advancement in the field.
Career Highlights
Chengxia Shu is affiliated with China Pharmaceutical University, where he continues to engage in research and development. His work emphasizes the importance of pharmacophore fusion and rational drug design, leading to the creation of novel dual-target inhibitors.
Collaborations
Chengxia Shu has collaborated with notable colleagues, including Xiaoxing Wu and Xiaoyu Chen, contributing to the advancement of medicinal chemistry through shared expertise and innovative research.
Conclusion
Chengxia Shu's work in developing dual-target inhibitors represents a significant step forward in addressing drug resistance in cancer treatment. His contributions to medicinal chemistry are paving the way for future advancements in pharmaceutical development.